PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+20.26%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.78B
AUM Growth
+$476M
(+21%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
4.26%
Top 10 Holdings %
Top 10 Hldgs %
41.05%
Holding
1,048
New
64
Increased
345
Reduced
583
Closed
56
Top Buys
| 1 |
NVIDIA
NVDA
|
$15.2M |
| 2 |
Microsoft
MSFT
|
$15.1M |
| 3 |
Apple
AAPL
|
$11.5M |
| 4 |
Shopify
SHOP
|
$10.5M |
| 5 |
Broadcom
AVGO
|
$8.66M |
Top Sells
| 1 |
Salesforce
CRM
|
$2.4M |
| 2 |
Arista Networks
ANET
|
$1.92M |
| 3 |
Snowflake
SNOW
|
$1.37M |
| 4 |
Insmed
INSM
|
$1.26M |
| 5 |
Exxon Mobil
XOM
|
$1.25M |
Sector Composition
| 1 | Technology | 46.81% |
| 2 | Communication Services | 11.24% |
| 3 | Consumer Discretionary | 11.17% |
| 4 | Healthcare | 8.44% |
| 5 | Financials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
BGC Group
BGC
$4.71B
| $176K | 0.01% |
17,227
+463
| +3% | +$4.74K |
|
|
ORLA
927
Orla Mining
ORLA
$3.82B
| $176K | 0.01% |
+17,582
| New | +$176K |
|
928
American Airlines Group
AAL
$8.63B
| $171K | 0.01% |
15,281
-789
| -5% | -$8.85K |
|
929
Fortuna Silver Mines
FSM
$2.35B
| $168K | 0.01% |
25,759
-659
| -2% | -$4.31K |
|
930
Eastern Bankshares
EBC
$3.44B
| $167K | 0.01% |
10,964
-224
| -2% | -$3.42K |
|
931
Xencor
XNCR
$610M
| $167K | 0.01% |
21,281
+987
| +5% | +$7.76K |
|
932
Spyre Therapeutics
SYRE
$1.03B
| $165K | 0.01% |
11,043
-3,619
| -25% | -$54.2K |
|
933
Mineralys Therapeutics
MLYS
$2.7B
| $164K | 0.01% |
+12,131
| New | +$164K |
|
934
Replimune Group
REPL
$494M
| $158K | 0.01% |
17,022
+188
| +1% | +$1.75K |
|
935
Expro
XPRO
$1.43B
| $157K | 0.01% |
18,320
+1,793
| +11% | +$15.4K |
|
936
Immunome
IMNM
$916M
| $154K | 0.01% |
16,537
-5,064
| -23% | -$47.1K |
|
937
Select Water Solutions
WTTR
$881M
| $153K | 0.01% |
17,730
+1,663
| +10% | +$14.4K |
|
938
CleanSpark
CLSK
$2.6B
| $153K | 0.01% |
13,837
+806
| +6% | +$8.89K |
|
939
Keros Therapeutics
KROS
$633M
| $152K | 0.01% |
11,421
-148
| -1% | -$1.98K |
|
940
Liquidia Corp
LQDA
$2.48B
| $152K | 0.01% |
12,212
-487
| -4% | -$6.07K |
|
941
Vir Biotechnology
VIR
$732M
| $152K | 0.01% |
30,176
-7,749
| -20% | -$39.1K |
|
942
CorMedix
CRMD
$926M
| $146K | 0.01% |
11,879
-601
| -5% | -$7.4K |
|
943
Wave Life Sciences
WVE
$1.32B
| $146K | 0.01% |
22,507
-10,738
| -32% | -$69.8K |
|
944
Cogent Biosciences
COGT
$1.82B
| $145K | 0.01% |
20,157
-14,738
| -42% | -$106K |
|
945
ImmunityBio
IBRX
$2.27B
| $144K | 0.01% |
54,412
-12,670
| -19% | -$33.4K |
|
946
Myriad Genetics
MYGN
$615M
| $140K | 0.01% |
26,398
-6,651
| -20% | -$35.3K |
|
947
Genworth Financial
GNW
$3.52B
| $136K | ﹤0.01% |
17,513
-1,286
| -7% | -$10K |
|
948
Day One Biopharmaceuticals
DAWN
$773M
| $136K | ﹤0.01% |
20,950
-3,653
| -15% | -$23.7K |
|
949
Relay Therapeutics
RLAY
$710M
| $134K | ﹤0.01% |
38,623
-4,306
| -10% | -$14.9K |
|
950
Kura Oncology
KURA
$713M
| $129K | ﹤0.01% |
22,357
-4,967
| -18% | -$28.7K |
|